Huang, Y., Kwan, M. L., Heckbert, S. R., Smith, N. L., Othus, M., Laurent, C. A., Roh, J. M., Rillamas-Sun, E., Lee, V. S., Kolevska, T., Cheng, R. K., Irribarren, C., Nguyen-Huynh, M., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2025). Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkaf009

Lardieri, A., Thaker, V., Citron-Zafrin, K., Garvin, J. H., Zacharoulis, S., & Ladas, E. J. (2024). Pharmacologic Management of Obesity in Neuro-Oncology: A Case Report. Case Reports in Oncology, 18(1), 169–173. Portico. https://doi.org/10.1159/000543178

Vaynrub, A., Mishalani, L., Raikhelkar, J., & Crew, K. D. (2024). Predictors of trastuzumab-induced cardiotoxicity among racially and ethnically diverse patients with HER2-positive breast cancer. Cardio-Oncology, 10(1). https://doi.org/10.1186/s40959-024-00272-8

Beaudry, R. I., Haykowsky, M. J., MacNamara, J. P., Tucker, W. J., Rao, R., Haley, B., & Sarma, S. (2022). Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors. Cardio-Oncology, 8(1). https://doi.org/10.1186/s40959-022-00134-1